Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Antihypertensive Drugs: Potassium-Sparing Diuretics

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

Antihypertensive Drugs: Action of Diuretics

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments.

European heart journal supplements : journal of the European Society of Cardiology·2019

Same author

Is Sacubitril/Valsartan Antifibrotic?

Journal of the American College of Cardiology·2019

Same author

Mid-term prognostic impact of residual pulmonary congestion assessed by radiographic scoring in patients admitted for worsening heart failure.

International journal of cardiology·2019

Same author

Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline.

European journal of heart failure·2019

Same author

Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial.

European journal of heart failure·2019

Same author

Nondipping Pattern and Cardiovascular and Renal Damage in a Population-Based Study (The STANISLAS Cohort Study).

American journal of hypertension·2019

Search research articles

Related Experiment Video

Updated: May 10, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

Loop diuretics and ultrafiltration in heart failure.

Patrick Rossignol¹, Faiez Zannad

¹INSERM, Centre d'Investigations Cliniques, Université de Lorraine and CHU de Nancy, 9501, UMR 1116, Vandoeuvre lès Nancy, France.

Expert Opinion on Pharmacotherapy

|June 26, 2013

Summary

This summary is machine-generated.

Loop diuretics are widely used for heart failure (HF) symptom relief, but their long-term effectiveness and safety remain unclear. Further research is needed to optimize HF treatment strategies.

Related Experiment Videos

Last Updated: May 10, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

Area of Science:

Cardiology
Nephrology

Background:

Loop diuretics are standard therapy for congestive heart failure (HF) symptom management.
Uncertainty exists regarding the long-term efficacy and safety of loop diuretics in HF.
The comparative efficacy and safety of loop diuretics versus venous ultrafiltration in acute decompensated HF are under investigation.

Purpose of the Study:

To review current data on the efficacy and safety of loop diuretics and ultrafiltration in HF patients.
To identify gaps in knowledge and suggest future research directions for optimizing HF management.

Main Methods:

Literature review of available data on loop diuretics and ultrafiltration in HF.
Analysis of current clinical guidelines and research findings.

Main Results:

Current literature provides limited long-term data on loop diuretic efficacy and safety in HF.
Venous ultrafiltration is being investigated as an alternative or adjunct therapy.

Conclusions:

There is a need for evidence-based algorithms to optimize treatment in HF.
Future algorithms should incorporate clinical signs, estimated glomerular filtration rate, electrolytes, and novel biomarkers (congestion, neurohumoral activation, kidney injury).
Optimizing the use of loop diuretics and renin-angiotensin-aldosterone system blockers is crucial for HF management.